Related Experiment Videos
Controlling hypertension in patients with diabetes
Sherri L Konzem1, Victoria S Devore, David W Bauer
1Memorial Family Practice Residency and University of Houston College of Pharmacy, Texas 77074, USA.
Insights
Hypertension and diabetes mellitus often coexist. Lowering blood pressure, especially with angiotensin-converting enzyme inhibitors, helps prevent diabetic complications, often requiring combination therapy.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Hypertension and diabetes mellitus are prevalent chronic diseases in the US.
- Diabetic patients exhibit a significantly higher prevalence of hypertension.
- Elevated blood pressure exacerbates diabetic complications.
Purpose of the Study:
- To review the management of hypertension in patients with diabetes mellitus.
- To highlight the benefits of blood pressure reduction in preventing diabetic complications.
- To discuss first-line and alternative antihypertensive therapies.
Main Methods:
- Review of existing literature on hypertension and diabetes management.
- Analysis of studies evaluating different antihypertensive drug classes.
- Emphasis on renal protective effects and combination therapy.
Main Results:
- Blood pressure reduction is crucial for preventing diabetic complications, irrespective of the agent used.
- Angiotensin-converting enzyme inhibitors are recommended as first-line therapy due to renal protection.
- Other agents like calcium channel blockers, diuretics, beta blockers, and alpha blockers have been studied.
- Combination therapy is frequently necessary to achieve blood pressure goals.
Conclusions:
- Effective blood pressure management is vital for patients with both diabetes and hypertension.
- Angiotensin-converting enzyme inhibitors offer significant renal benefits in this population.
- Achieving optimal blood pressure control often necessitates a multi-drug approach.
Abstract:
Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications. Barring contraindications, angiotensin-converting enzyme inhibitors are considered first-line therapy in patients with diabetes and hypertension because of their well-established renal protective effects. Calcium channel blockers, low-dose diuretics, beta blockers, and alpha blockers have also been studied in this group. Most diabetic patients with hypertension require combination therapy to achieve optimal blood pressure goals.